SCHEMBL30865234

SCHEMBL30865234

O=C(N1CC2(CC(n3cnc(C(F)(F)F)n3)C2)C1)N1CC2(CN(Cc3ccn(CC(F)(F)F)n3)C2)C1

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 6/20 0.44
▸ SCN1A P35498 1/20 0.30
▸ SCN8A Q9UQD0 1/20 0.30
▸ BTK Q06187 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30865339 0.91 MGLL (0.40) MGLL
SCHEMBL30865263 0.88 MGLL (0.57) MGLL
SCHEMBL30865306 0.88 MGLL (0.41) MGLL
SCHEMBL30865192 0.87 MGLL (0.44) MGLL
SCHEMBL30865384 0.84 MGLL (0.44) MGLLBTK
SCHEMBL30865152 0.83 MGLL (0.49) MGLLSCN1ASCN8A
SCHEMBL30865483 0.83 MGLL (0.45) MGLLBTK
SCHEMBL30865248 0.83 MGLL (0.43) MGLL
SCHEMBL30865281 0.82 MGLL (0.44) MGLLBTK
SCHEMBL30865242 0.82 MGLL (0.43) MGLLBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608823-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. Hoffmann-La Roche AG (CH) 2025-09-03 — — EP claimed
WO-2024088922-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. HOFFMANN-LA ROCHE AG (CH) 2024-05-02 — — WO claimed
EP-4608823-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. Hoffmann-La Roche AG (CH) 2025-09-03 — — EP disclosed
WO-2024088922-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. HOFFMANN-LA ROCHE AG (CH) 2024-05-02 — — WO disclosed
Send feedback